Asceneuron is a biotech company that specializes in small molecule drug discovery for neurodegenerative diseases, particularly orphan tauopathies and Alzheimer's disease. Tauopathies are neurodegenerative diseases that currently have no treatment and rapidly progress to debilitating conditions. Asceneuron aims to become a leading company in this field by focusing on areas of high unmet medical nee...